<p>对于 <strong>鸿通电子</strong>（SGX:BN2）的股东来说，这一周过得不错，因为公司刚刚发布了最新的年度业绩，股价上涨了 5.2%，达到了 0.70 新元。业绩看起来有些混合——虽然收入略微低于分析师的预期，为 17 亿港元，但法定每股收益符合预期，为 0.41 港元。这对投资者来说是一个重要时刻，因为他们可以在报告中跟踪公司的表现，查看专家对明年的预测，并看看对业务的预期是否有任何变化。读者会高兴地知道，我们汇总了最新的法定预测，以查看分析师在最新业绩发布后是否改变了对鸿通电子的看法。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/33257368-earnings-and-revenue-growth-1-dark-2/1748738314580?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/33257368-earnings-and-revenue-growth-1-dark-2/1748738314580"/></p>
<p>SGX:BN2 收益和收入增长 2025 年 6 月 1 日</p>
<p>在最新业绩发布后，唯一覆盖鸿通电子的分析师现在预测 2026 年的收入为 18.3 亿港元。如果实现，这将反映出与过去 12 个月相比，收入有一个不错的 5.8% 的改善。法定每股收益预计将增加 4.0%，达到 0.44 港元。然而，在最新收益之前，分析师曾预计 2026 年的收入为 19.2 亿港元，每股收益（EPS）为 0.43 港元。共识似乎有些悲观，在最新业绩发布后削减了收入预测，尽管每股收益的预期没有变化。</p>
<p>请查看我们对鸿通电子的最新分析</p>
<p>共识重新确认了其价格目标为 0.79 新元，显示分析师不认为明年的收入预期减弱会对鸿通电子的市场价值产生实质性影响。</p>
<p>我们可以从更大的背景来看待这些预测，例如这些预测与过去表现的对比，以及相对于行业内其他公司的预测是更乐观还是更悲观。例如，我们注意到鸿通电子的增长率预计将显著加快，预计到 2026 年底收入将以年化 5.8% 的速度增长。这远高于过去五年每年 6.9% 的历史下降率。相比之下，我们的数据表明，行业内其他公司（有分析师覆盖）的收入预计将每年增长 13%。因此，尽管鸿通电子的收入增长预计会改善，但仍然预计会低于行业水平。</p>
<p><img src="https://imageproxy.pbkrs.com/https://media.simplywall.st/news/1748322310639-Valuation_banner.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://media.simplywall.st/news/1748322310639-Valuation_banner.png"/></p>
<h2>结论</h2>
<p>最明显的结论是，最近业务前景没有重大变化，分析师保持了他们的收益预测，与之前的估计一致。在负面方面，他们也下调了收入预期，预测表明它们的表现将低于更广泛的行业。尽管如此，收益对企业的内在价值更为重要。共识价格目标保持在 0.79 新元，最新的估计不足以对其价格目标产生影响。</p>
<p>考虑到这一点，我们仍然认为，企业的长期发展轨迹对投资者来说更为重要。至少有一位分析师提供了到 2028 年的预测，可以在我们的平台上免费查看。</p>
<p>不要忘记，仍然可能存在风险。例如，我们已经识别出 <strong>鸿通电子的 2 个警告信号</strong>，您应该注意。</p>

鸿通电子

<p>威尔通控股有限公司（SGX:BN2）公布了混合的年度业绩，收入略低于分析师预期，达到 17 亿港元，而每股收益符合预期，为 0.41 港元。业绩公布后，分析师预测 2026 年收入将增加至 18.3 亿港元，增长 5.8%，但下调了之前的预测。共识目标价维持在 0.79 新加坡元，尽管收入预期较弱，但市场价值仍然稳定。总体而言，尽管盈利预测保持稳定，收入增长预计将落后于行业同行，投资者面临潜在风险</p>

<p>It's been a good week for <strong>Valuetronics Holdings Limited</strong> (SGX:BN2) shareholders, because the company has just released its latest yearly results, and the shares gained 5.2% to S$0.70. Results look mixed - while revenue fell marginally short of analyst estimates at HK$1.7b, statutory earnings were in line with expectations, at HK$0.41 per share. This is an important time for investors, as they can track a company's performance in its report, look at what expert is forecasting for next year, and see if there has been any change to expectations for the business. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analyst has changed their mind on Valuetronics Holdings after the latest results.</p>
<div class="lb-trans"><p>对于 <strong>鸿通电子</strong>（SGX:BN2）的股东来说，这一周过得不错，因为公司刚刚发布了最新的年度业绩，股价上涨了 5.2%，达到了 0.70 新元。业绩看起来有些混合——虽然收入略微低于分析师的预期，为 17 亿港元，但法定每股收益符合预期，为 0.41 港元。这对投资者来说是一个重要时刻，因为他们可以在报告中跟踪公司的表现，查看专家对明年的预测，并看看对业务的预期是否有任何变化。读者会高兴地知道，我们汇总了最新的法定预测，以查看分析师在最新业绩发布后是否改变了对鸿通电子的看法。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/33257368-earnings-and-revenue-growth-1-dark-2/1748738314580" alt="" original-src="https://images.simplywall.st/asset/chart/33257368-earnings-and-revenue-growth-1-dark-2/1748738314580"/></p>
<p>SGX:BN2 Earnings and Revenue Growth June 1st 2025</p>
<div class="lb-trans"><p>SGX:BN2 收益和收入增长 2025 年 6 月 1 日</p>
</div><p>After the latest results, the single analyst covering Valuetronics Holdings are now predicting revenues of HK$1.83b in 2026. If met, this would reflect an okay 5.8% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to increase 4.0% to HK$0.44. Yet prior to the latest earnings, the analyst had been anticipated revenues of HK$1.92b and earnings per share (EPS) of HK$0.43 in 2026. The consensus seems maybe a little more pessimistic, trimming their revenue forecasts after the latest results even though there was no change to its EPS estimates.</p>
<div class="lb-trans"><p>在最新业绩发布后，唯一覆盖鸿通电子的分析师现在预测 2026 年的收入为 18.3 亿港元。如果实现，这将反映出与过去 12 个月相比，收入有一个不错的 5.8% 的改善。法定每股收益预计将增加 4.0%，达到 0.44 港元。然而，在最新收益之前，分析师曾预计 2026 年的收入为 19.2 亿港元，每股收益（EPS）为 0.43 港元。共识似乎有些悲观，在最新业绩发布后削减了收入预测，尽管每股收益的预期没有变化。</p>
</div><p>See our latest analysis for Valuetronics Holdings</p>
<div class="lb-trans"><p>请查看我们对鸿通电子的最新分析</p>
</div><p>The consensus has reconfirmed its price target of S$0.79, showing that the analyst doesn't expect weaker revenue expectations next year to have a material impact on Valuetronics Holdings' market value.</p>
<div class="lb-trans"><p>共识重新确认了其价格目标为 0.79 新元，显示分析师不认为明年的收入预期减弱会对鸿通电子的市场价值产生实质性影响。</p>
</div><p>Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. For example, we noticed that Valuetronics Holdings' rate of growth is expected to accelerate meaningfully, with revenues forecast to exhibit 5.8% growth to the end of 2026 on an annualised basis. That is well above its historical decline of 6.9% a year over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 13% per year. So although Valuetronics Holdings' revenue growth is expected to improve, it is still expected to grow slower than the industry.</p>
<div class="lb-trans"><p>我们可以从更大的背景来看待这些预测，例如这些预测与过去表现的对比，以及相对于行业内其他公司的预测是更乐观还是更悲观。例如，我们注意到鸿通电子的增长率预计将显著加快，预计到 2026 年底收入将以年化 5.8% 的速度增长。这远高于过去五年每年 6.9% 的历史下降率。相比之下，我们的数据表明，行业内其他公司（有分析师覆盖）的收入预计将每年增长 13%。因此，尽管鸿通电子的收入增长预计会改善，但仍然预计会低于行业水平。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://media.simplywall.st/news/1748322310639-Valuation_banner.png" alt="" original-src="https://media.simplywall.st/news/1748322310639-Valuation_banner.png"/></p>
<h2>The Bottom Line</h2>
<div class="lb-trans"><h2>结论</h2>
</div><p>The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analyst holding their earnings forecasts steady, in line with previous estimates. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. Still, earnings are more important to the intrinsic value of the business. The consensus price target held steady at S$0.79, with the latest estimates not enough to have an impact on their price target.</p>
<div class="lb-trans"><p>最明显的结论是，最近业务前景没有重大变化，分析师保持了他们的收益预测，与之前的估计一致。在负面方面，他们也下调了收入预期，预测表明它们的表现将低于更广泛的行业。尽管如此，收益对企业的内在价值更为重要。共识价格目标保持在 0.79 新元，最新的估计不足以对其价格目标产生影响。</p>
</div><p>Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At least one analyst has provided forecasts out to 2028, which can be seen for free on our platform here.</p>
<div class="lb-trans"><p>考虑到这一点，我们仍然认为，企业的长期发展轨迹对投资者来说更为重要。至少有一位分析师提供了到 2028 年的预测，可以在我们的平台上免费查看。</p>
</div><p>Don't forget that there may still be risks. For instance, we've identified <strong>2 warning signs for Valuetronics Holdings</strong> that you should be aware of.</p>
<div class="lb-trans"><p>不要忘记，仍然可能存在风险。例如，我们已经识别出 <strong>鸿通电子的 2 个警告信号</strong>，您应该注意。</p>
</div>

鸿通电子控股有限公司（SGX:BN2）刚刚公布了年度财报：分析师对该股票的看法是否有所改变？